Admission Date:  [**2152-9-21**]              Discharge Date:   [**2152-9-23**]  Date of Birth:  [**2103-2-23**]             Sex:   M  Service: CARDIOTHORACIC  Allergies: Adhesive Tape  Attending:[**Known firstname 922**] Chief Complaint: Failed LV lead placement  Major Surgical or Invasive Procedure: [**2152-9-21**] - Thoracoscopic LV Lead Placement   History of Present Illness: This 49 year old male has an extensive history of coronary artery  disease, dating back to [**2139**] when he had his first stent placed.
Since then, he has had multiple stents placed to the LAD, LCX and RCA.
He was recently evaluated by Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] for biventricular ICD placement and was found to meet criteria.
He returned to the device clinic on [**2152-9-13**] when he developed stimulation of his diaphram causing continuous hiccups.
He is now admitted for a thoracosopic LV lead placement.
Past Medical History: Coronary artery disease status post multiple stent placements in the LAD, left circumflex, and right coronary artery beginning  in [**2139**] with subsequent interventions in [**2148**], [**2150**], and most recently drug-eluting stents placed in the distal right in 12/[**2150**].
Hypertension Hyperlipidemia Diabetes Cardiomyopathy, s/p BiV ICD placementon [**2152-9-11**] LBBB Substance abuse in the [**2113**]/[**2123**] with marijuana, acid, ETOH; denies using drugs presently   Social History: Married with 3 children.
His wife will bring him to the procedure and can be reached at [**Telephone/Fax (1) 41991**].
Family History: father had a stent placed at age 73. mother has a LBBB.
Pertinent Results: [**2152-9-22**] 02:14AM BLOOD WBC-12.8* RBC-3.75* Hgb-11.6* Hct-32.6* MCV-87 MCH-31.0 MCHC-35.7* RDW-14.7 Plt Ct-281 [**2152-9-21**] 09:10AM BLOOD WBC-5.4 RBC-3.81* Hgb-11.7* Hct-33.3* MCV-88 MCH-30.8 MCHC-35.1* RDW-14.6 Plt Ct-255 [**2152-9-21**] 01:25PM BLOOD PT-13.8* PTT-20.3* INR(PT)-1.2* [**2152-9-21**] 09:10AM BLOOD PT-13.7* PTT-22.0 INR(PT)-1.2* [**2152-9-23**] 07:20AM BLOOD UreaN-16 Creat-0.9 K-4.2 [**2152-9-21**] 01:25PM BLOOD UreaN-18 Creat-0.8 Na-138 Cl-104 HCO3-24     [**Known lastname 41992**],[**Known firstname 177**] E. [**Age over 90 41993**] M  49  [**2103-2-23**]  Radiology Report CHEST (PORTABLE AP) Study Date of [**2152-9-22**] 9:25 AM   [**Last Name (LF) **],[**Known firstname 177**] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) 5204**] CSRU [**2152-9-22**] SCHED CHEST (PORTABLE AP)   Clip # [**Clip Number (Radiology) 41994**] Reason: PTX    [**Hospital 93**] MEDICAL CONDITION:    49 year old man s/p Left thoracoscopy/pacer lead placement REASON FOR THIS EXAMINATION:    PTX    Provisional Findings Impression: LCpc FRI [**2152-9-22**] 6:50 PM No pneumothorax.
Final Report CHEST, PORTABLE AP  REASON FOR EXAM: 49-year-old man status post left thoracoscopy/pacer lead placement.
Since earlier today, the left chest tube was removed.
DR. [**First Name8 (NamePattern2) 4078**] [**Name (STitle) 4079**] DR. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 4130**] Approved: SAT [**2152-9-23**] 8:34 AM    Imaging Lab    Brief Hospital Course: Mr. [**Known lastname **] was admitted to the [**Hospital1 18**] on [**2152-9-21**] for surgical placement of his LV lead.
He was taken directly to the operating room where he underwent a thoracoscopic LV lead placement.
He was treated per CP protocol: NTG SL/O2/MSO4.
Medications on Admission: Metformin 500 mg PO BID Lisinopril 20 mg PO DAILY Aspirin 325 mg Metoprolol Succinate 50 mg Tablet  Discharge Medications: 1.
Metformin 500 mg Tablet Sig: 1.5 Tablets PO BID (2 times a day).
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 325 mg Tablet, Delayed Release (E.C.)
Furosemide 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 3 days.
Potassium Chloride 20 mEq Packet Sig: One (1) Packet PO Q12H (every 12 hours) for 3 days.
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
Outpatient Lab Work CXR: PA/LAT->s/p left thorascopic LV lead placement 2 weeks after discharge   Discharge Disposition: Home with Service  Discharge Diagnosis: [**2152-9-21**] - Thoracoscopic LV Lead Placement   Discharge Condition: Stable   Discharge Instructions: 1)  Monitor wounds for signs of infection.
These include redness, drainage or increased pain.
4)  No lotions, creams or powders to incision until it has healed.
Use sunscreen on incision if exposed to sun.
